PCM TARGETECH, LLC
2Patents
2Active
2Granted
39Portfolio score
Filing activity: Aug 1, 2019 → Feb 10, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11208494B2 | Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy | Chemistry; Metallurgy | 1 | Active |
| US11753477B2 | Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug conjugate thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.